01515.HK
China Resources Medical Holdings Company Limited
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 2.52
+0.40%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 18.5B | 9.2B | 9.9B | 10.1B | 7.9B |
| Cost of Revenue | 15.4B | 7.7B | 8.0B | 8.2B | 4.6B |
| Gross Profit | 3.0B | 1.4B | 1.8B | 1.9B | 1.3B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 2.0B | 1.0B | 1.0B | 973.5M | 828.2M |
| General & Admin Expense | 1.6B | 995.9M | 1.0B | 970.8M | 808.7M |
| Selling & Marketing Expense | 20.6M | 22.4M | 623.0K | 2.7M | 19.5M |
| Other Expenses | — | — | (14.4M) | 79.7M | (51.9M) |
| Total Operating Expenses | 2.0B | 1.0B | 1.0B | 1.1B | 776.3M |
| Cost and Expenses | 17.5B | 8.8B | 9.1B | 9.3B | 7.5B |
| Operating Income (EBIT) | 978.9M | 422.5M | 775.0M | 852.4M | 441.5M |
| Non-Operating | |||||
| Interest Income | 19.3M | 10.2M | 14.2M | 68.4M | 93.3M |
| Interest Expense | 89.9M | 48.3M | 61.0M | 114.9M | 55.9M |
| Net Interest Income | (81.5M) | (38.1M) | (61.1M) | (46.5M) | 40.7M |
| Other Non-Op Income/Expense | 368.8M | 325.2M | 63.7M | (359.5M) | (18.6M) |
| Non-Operating Income (excl Interest) | 10.3M | — | 22.3M | 244.6M | (8.1M) |
| EBT (Pre-Tax Income) | 1.3B | 747.7M | 838.7M | 492.9M | 422.9M |
| Income Tax Expense | 316.5M | 191.6M | 166.9M | 165.0M | 94.7M |
| Bottom Line | |||||
| Net Income | 889.1M | 495.9M | 565.9M | 257.7M | 265.9M |
| Earnings from Cont. Ops | 1.0B | 556.1M | 671.7M | 327.9M | 328.3M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 889.1M | 495.9M | 565.9M | 257.7M | 265.9M |
| Per Share | |||||
| Basic EPS | HK$0.71 | HK$0.39 | HK$0.45 | HK$0.20 | HK$0.21 |
| Diluted EPS | HK$0.71 | HK$0.39 | HK$0.45 | HK$0.20 | HK$0.21 |
| Revenue Per Share | HK$14.61 | HK$7.26 | HK$7.79 | HK$7.99 | HK$6.26 |
| Shares | |||||
| Basic Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| Diluted Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| Profitability Metrics | |||||
| EBITDA | 2.1B | 946.6M | 1.3B | 1.2B | 965.2M |
| D&A | 1.1B | 524.1M | 559.1M | 610.9M | 486.4M |
| EBIT | 968.6M | 422.5M | 752.7M | 607.8M | 478.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026